Skip to main content

Published locations for Subcutaneous ocrelizumab, ofatumumab ‘reassuring’ in MS

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. Subcutaneous ocrelizumab, ofatumumab ‘reassuring’ in MS

User login

  • Reset your password
  • /content/subcutaneous-ocrelizumab-ofatumumab-reassuring-ms
  • /internalmedicinenews/article/266163/multiple-sclerosis/subcutaneous-ocrelizumab-ofatumumab
  • /neurologyreviews/article/266163/multiple-sclerosis/subcutaneous-ocrelizumab-ofatumumab-reassuring-ms
  • /internalmedicine/article/266163/multiple-sclerosis/subcutaneous-ocrelizumab-ofatumumab-reassuring-ms
  • /neurology/article/266163/multiple-sclerosis/subcutaneous-ocrelizumab-ofatumumab-reassuring-ms
  • /neurology/msresourcecenter/article/266163/multiple-sclerosis/subcutaneous-ocrelizumab-ofatumumab